Agnete B. Fredriksen

Co-founder, Chief Innovation and Strategy Officer at Vaccibody AS.

[Agnete B. Fredriksen @ABFredriksen]

Joining forces with >60 leaders in immunology to encourage FDA to increase the focus on T cell responses in COVID-19 and infectious diseases in general.

[E. John Wherry @EJohnWherry]

Here is the full text of the letter to the FDA about T cell responses in COVID vaccine studies.

[Agnete B. Fredriksen @ABFredriksen]

Når grundertilværelsen føles ekstra meningsfull🌟 https://t.co/FOa0HE9IE1

[Agnete B. Fredriksen @ABFredriksen]

We select our partners carefully! Enjoy the collaboration with the competent team at Adaptive Biotechnologies generating 3rd generations vaccines. Listen to the webcast at 4 pm today. https://t.co/0gYabSuZmW

[Agnete B. Fredriksen @ABFredriksen]

This is an amazing achievement by the entire Vaccibody family! Thanks to the patients, investigators, collaborators and all Vaccibody team members for the dedication to this important study. https://t.co/Umm89phNCH

[Agnete B. Fredriksen @ABFredriksen]

Proud and excited for reaching this milestone! Rewarding to work with JZ and the rest of the Nektar team.

[Nektar Therapeutics @NektarNews]

We are excited to announce we reached an important milestone in our partnership with Vaccibody, dosing the first patient in our Phase 1/2a study arm evaluating the combination of bempeg with VB10.NEO. Read more: https://t.co/z4CYKcxmNq

[Agnete B. Fredriksen @ABFredriksen]

@eivindhaugan Never uncross, Eivind!!😉 Thanks for all your support.

[Agnete B. Fredriksen @ABFredriksen]

Very excited about the strong signs of vaccine-induces clinical responses, backed up with a range of scientificly sound correlations, in our cancer neoantigen vaccine trial!
https://t.co/sK3aDvxBYm #cancerresearch #cancervaccine #neoantigens

[Agnete B. Fredriksen @ABFredriksen]

New times in Vaccibody! Thx to Martin for 4 great years! And a warm welcome to Michael! Ready for next phase💪🏼 https://t.co/E4A6qY4VP1

[Agnete B. Fredriksen @ABFredriksen]

Thanks for the invite and opportunity to share my journey. Really enjoyed the entire program and the interactive discussions!

[Labiotech.eu @Labiotech_eu]

Last fireside chat before our Panel! Wonderful to have @Vaccibody President & CSO Agnete Fredriksen sharing with us - “How to manage the #science of a #biotech company”!

[Agnete B. Fredriksen @ABFredriksen]

@eivindhaugan @Labiotech_eu She is very excited, Eivind:-)

[Labiotech.eu @Labiotech_eu]

🎤 Speaker #1 - We're thrilled to have Agnete Fredriksen @ABFredriksen, CSO of @Vaccibody, join us at Labiotech Insider Day! Take a sneak peek at the program & register today! 👉🏻 https://t.co/CBRT8hUOb9 👈🏻 #biotech #LBRefresh

[Agnete B. Fredriksen @ABFredriksen]

In San Francisco speaking at the Mol Med Tri-Con while TV2 tells about our Roche collaboration. Exciting days. https://t.co/afBFtfk0pB

[Agnete B. Fredriksen @ABFredriksen]

And then the 230 MNOK was secured! Thanks for the strong support and interest from our investors!
https://t.co/Kqh7cBA40H

[Agnete B. Fredriksen @ABFredriksen]

Vaccibody is excited to announce a Collaboration With Roche combining VB10.16 and Atezolizumab in Cervical Cancer!

https://t.co/DitFEEp8Vq

[RADFORSK @radforsk]

NRK EKKO har laget et flott radioinnslag om vår porteføljebedrift Vaccibody der @ABFredriksen forteller om hvordan de utvikler persontilpassede kreftvaksiner: https://t.co/3WmtT3s9wr #helsenæring #kreft

[Agnete B. Fredriksen @ABFredriksen]

Finansavisen lørdag- hvorfor er Vaccibody og Nektar så gode partnere?

[Nektar Therapeutics @NektarNews]

We’ve entered into a new clinical collaboration with Vaccibody to combine their personalized neo-antigen cancer vaccine with NKTR-214. Learn more about this combination's design to harness specific T cell clonal expansion in the fight against cancer: https://t.co/i70yWqcMpY

[Agnete B. Fredriksen @ABFredriksen]

So excited to announce this highly interesting clinical collaboration with Nektar Therapeutics! https://t.co/kMLiNHuYaL

[Agnete B. Fredriksen @ABFredriksen]

Trying to convince our Minister of Trade and Industry to create better incentiver for startup and founders:-) #timeforchange #startup #politicians

[RADFORSK @radforsk]

Ny pod er ute nå. @elikirand har besøk av @ABFredriksen og Martin Bonde fra vår porteføljebedrift #Vaccibody: Vi snakker om utviklingen av deres persontilpassede kreftvaksine og planer for framtiden https://t.co/wcoBJFPtwP